Evidence map›Paper›PMID 41878117›Full record

ReviewFrontiers in pain research (Lausanne, Switzerland)2026

Platelet-rich plasma for treatment of knee osteoarthritis: a narrative review.

Samuel L Patton, Kelsey Gustafson, Matt Castinado, Usman Latif, Dawood Sayed, Talal W Khan, Christopher M Lam

Abstract readReview
In one paragraph

Review in Frontiers in pain research (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samuel L PattonDepartment of Anesthesiology, Pain, and Perioperative Medicine, The University of Kansas Health System, Kansas City, KS, United States.
Kelsey GustafsonDepartment of Anesthesiology, Pain, and Perioperative Medicine, The University of Kansas Health System, Kansas City, KS, United States.
Matt CastinadoDepartment of Anesthesiology, Pain, and Perioperative Medicine, The University of Kansas Health System, Kansas City, KS, United States.
Usman LatifDepartment of Anesthesiology, Pain, and Perioperative Medicine, The University of Kansas Health System, Kansas City, KS, United States.
Dawood SayedDepartment of Anesthesiology, Pain, and Perioperative Medicine, The University of Kansas Health System, Kansas City, KS, United States.
Talal W KhanDepartment of Anesthesiology, Pain, and Perioperative Medicine, The University of Kansas Health System, Kansas City, KS, United States.
Christopher M LamDepartment of Anesthesiology, Pain, and Perioperative Medicine, The University of Kansas Health System, Kansas City, KS, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis is the most common cause of arthritis, a pervasive condition affecting various joints within the human body. The culmination of various factors resulting in degradation and damage of healthy cartilage initiates the cascade of degenerative changes which contribute to the development of this condition, affecting about 73% of all adults older than age 55. Various treatments are available to help treat this condition. Prevention often includes the utilization of physical therapy, exercise, and weight management while treatment of the resultant joint pain includes bracing, medications, and interventional treatments including steroid and visco supplementation techniques. Within the past two decades, particular interest has developed in utilizing regenerative methods for treatment of these degenerative conditions. One such treatment is platelet rich plasma. Here we review the salient conceptions of this treatment and provide a brief overview of the evidence and healthcare impact regarding its utilization.

Indexed as

interventional painknee osteoarthritispain managementplatelet-rich plasma (PRP)regenerative medicine

Identifiers

PMID41878117
PMCPMC13006636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.